Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity
about
Human NKG2D-ligands: cell biology strategies to ensure immune recognitionRegulation of immune cell function and differentiation by the NKG2D receptorHuman cytomegalovirus and autoimmune diseaseCD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequenceStructure of the HCMV UL16-MICB Complex Elucidates Select Binding of a Viral Immunoevasin to Diverse NKG2D LigandsCrystal Structure of the Cowpox Virus-Encoded NKG2D Ligand OMCPIdentification and Function of MicroRNAs Encoded by HerpesvirusesGenomic organization and evolution of the ULBP genes in cattleQuantitative temporal viromics: an approach to investigate host-pathogen interactionDistinct expression profile of HCMV encoded miRNAs in plasma from oral lichen planus patients.Controlling cytomegalovirus: helping the immune system take the leadSelective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoproteinThe activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure.N-glycosylation of asparagine 8 regulates surface expression of major histocompatibility complex class I chain-related protein A (MICA) alleles dependent on threonine 24.Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expressionCurrent knowledge of MicroRNAs and noncoding RNAs in virus-infected cells.The human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICBCervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implicationsRegulation and gene expression profiling of NKG2D positive human cytomegalovirus-primed CD4+ T-cells.Modulation of CD112 by the alphaherpesvirus gD protein suppresses DNAM-1-dependent NK cell-mediated lysis of infected cells.Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells.Host immune system gene targeting by a viral miRNANK cells and their ability to modulate T cells during virus infectionsCMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.NK cells, innate immunity and hepatitis C infection after liver transplantation.Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation.How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillanceNatural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation.Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cellsSynergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretionCytomegalovirus following stem cell transplantation: from pharmacologic to immunologic therapy.Viral modulation of NK cell immunity.Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virusRoles of host and viral microRNAs in human cytomegalovirus biologyHuman herpesviridae methods of natural killer cell evasionNatural Killer Cell Evasion Is Essential for Infection by Rhesus CytomegalovirusReevaluation of the coding potential and proteomic analysis of the BAC-derived rhesus cytomegalovirus strain 68-1.Zoonotic orthopoxviruses encode a high-affinity antagonist of NKG2D.Viral strategies for evading antiviral cellular immune responses of the host.
P2860
Q21131219-68A4D4BA-36D8-4039-B854-8A55B9AD1AB2Q24635093-B635E126-9FD7-4B22-BE4D-8B08A423BE7AQ26850549-9A9BEA02-B97C-4C87-A827-F07FFB146ACAQ27650047-BBB65D9F-09FB-407A-99E1-8DD57B9630A0Q27659082-A90C5E99-6BD4-4138-94FF-92E1B95065E3Q27674864-B4AC6D03-EE78-42CA-9EF5-32669F1C3E97Q28749288-2EC79054-CF11-4698-82CC-6885D3558988Q33256432-FBF38757-4C91-45BA-A47D-5313FA8D2BCAQ33722378-5A68E09C-1386-4C24-A1BA-75E01C9E1593Q33776574-4AD76D3B-4928-49BF-966E-ED70C4DC5B53Q33820695-1CC4A582-6FA3-46CB-8614-9041E9483918Q33834018-FC189525-D668-433E-AF13-5112EBDA7E4FQ33836365-2833C118-CC81-4853-8FE3-C932EDFC4171Q33931165-D143DB00-83A0-403A-880C-DEA066710030Q33999130-B7E3417F-D3B3-4FE8-B555-39702C2A563EQ34003311-708AFDCB-375F-485A-B59D-0EAEB2CC5D45Q34079158-BAE7F1EE-F76B-4EBE-829A-7017C7D3A4ECQ34153620-802D5AEC-D5C6-491E-B783-8DAE4B2DD2DDQ34368956-037E45F8-3C57-4227-8EC3-38636CA5D61FQ34526520-CD223398-FE70-4DAB-AE00-E2C4D7533310Q34551199-CC42C90B-1F2D-45F1-8042-5EA60A1502B4Q34581221-9F5A7F5A-A29E-415F-A69E-B35772A98E75Q34700499-52637C68-6A4D-48CD-9280-4DE52F99C38BQ34946005-EA1B05CB-17A6-4043-8671-F3F00713D5BBQ35019869-522DBC91-44C2-47FA-A7B0-93804BBA617AQ35031677-AA78AFA9-7615-4049-AE7D-904D57383905Q35099535-D2018E5E-466C-405D-9B7B-73D02CE427C1Q35678024-58718427-8E86-4294-85FB-241F5EDB1F62Q35795227-466E4A72-18C1-40A4-B92D-5FA6D85B881CQ35803399-49065EA7-2EBC-4D9C-8A77-7DC7D3012AF5Q35848493-D860E8CA-7BC8-41BE-A5B6-9D1E5F8D9C50Q35917480-26B889B2-AE55-4CAA-8951-DEE06157493BQ35988761-B32F33B0-6F3C-4DBC-B2BD-1143ECEB60DCQ36024214-01F2C84F-4E8E-4585-8F78-531765FE30D6Q36060243-A45B1452-A49E-45C3-AF4F-F3D13DA78E37Q36102137-904FBC1D-A8EF-4C16-A1B8-6F280FB0AFFCQ36118554-0B3C52F6-42FD-4284-AA5C-5D1B8D18DB28Q36154996-7701A4C4-8A93-4F18-9322-880739531553Q36229447-0F184BA3-43D6-4C8C-B91C-9251B1F769FAQ36276589-1C897189-F34F-403A-A874-5332BFD3894B
P2860
Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@ast
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@en
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@en-gb
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@nl
type
label
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@ast
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@en
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@en-gb
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@nl
prefLabel
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@ast
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@en
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@en-gb
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@nl
P2093
P2860
P921
P3181
P356
P1476
Human cytomegalovirus glycopro ...... tural killer cell cytotoxicity
@en
P2093
Claire Dunn
Claire L Sutherland
David C Johnson
David Cosman
N Jan Chalupny
P V Sivakumar
Stephanie Dosch
P2860
P304
P3181
P356
10.1084/JEM.20022059
P407
P577
2003-06-02T00:00:00Z